Tumor budding correlates with the protumor immune microenvironment and is an independent prognostic factor for recurrence of stage i lung adenocarcinoma Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Biomarkers, Tumor
  • Lung Neoplasms
  • Neoplasm Recurrence, Local

abstract

  • Tumor budding is an independent prognostic factor of stage I lung adenocarcinoma and correlates with the protumor immune microenvironment. Our findings advocate investigating tumor-immune cell interactions at the invading edge as a biologic driver of tumor aggressiveness.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4556124

Digital Object Identifier (DOI)

  • 10.1378/chest.14-3005

PubMed ID

  • 25836013

Additional Document Info

start page

  • 711

end page

  • 21

volume

  • 148

number

  • 3